Before using this medication, inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding
Ready-to-Use:Vials are individually sealed for single-use to maintain sterility and minimize waste
Pregnancy or breastfeeding No human safety data
The Phase 2b OPTIONS trial 536 obese subjects, randomized to receive 0.25, 0.5, or 1 mg/day oral AOD-9604 or placebo over 24 weeks failed to demonstrate statistically significant weight loss at any dose tested
Kinetic and X-ray [PMID: 6697994] Laboratory literature summary: Interaction of a glutathione S-conjugate with glutathione reductase
Guttides brings these two peptides together in a convenient supplement, making it easier than ever to support your body's natural healing processes